img

Global IL-17 Antibody Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global IL-17 Antibody Market Insights, Forecast to 2034

Antibodies are?proteins that protect you when an unwanted substance enters your body.
Market Analysis and InsightsGlobal IL-17 Antibody Market
Global IL-17 Antibody market is expected to reach to US$ 12 million in 2024, with a positive growth of %, compared with US$ 10 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, IL-17 Antibody industry is evaluated to reach US$ 36 million in 2029. The CAGR will be 20.0% during 2024 to 2029.
A surge in research and development activities among pharmaceutical market leaders to develop economical andeffective antibodies and biosimilar antibodies is driving growth opportunities for the antibodies market.
Report Covers
This report presents an overview of global IL-17 Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global IL-17 Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher Scientific
ProSci
FineTest
Sino Biological
Miltenyi Biotec
Merck
Santa Cruz Biotechnology
Proteintech
United States Biological
BioLegend
Bio-Rad
Bio X Cell
Hytest
Everest Biotech
Segment by Type
Polyclonal
Monoclonal

Segment by Application


Enzyme Linked Immunosorbent Assay
Immunohistochemistry Frozen
Immunohistochemistry Paraffin
Western Blot
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, IL-17 Antibody introduction, etc. IL-17 Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of IL-17 Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IL-17 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global IL-17 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Enzyme Linked Immunosorbent Assay
1.3.3 Immunohistochemistry Frozen
1.3.4 Immunohistochemistry Paraffin
1.3.5 Western Blot
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IL-17 Antibody Market Perspective (2018-2029)
2.2 Global IL-17 Antibody Growth Trends by Region
2.2.1 IL-17 Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 IL-17 Antibody Historic Market Size by Region (2018-2024)
2.2.3 IL-17 Antibody Forecasted Market Size by Region (2024-2029)
2.3 IL-17 Antibody Market Dynamics
2.3.1 IL-17 Antibody Industry Trends
2.3.2 IL-17 Antibody Market Drivers
2.3.3 IL-17 Antibody Market Challenges
2.3.4 IL-17 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue IL-17 Antibody by Players
3.1.1 Global IL-17 Antibody Revenue by Players (2018-2024)
3.1.2 Global IL-17 Antibody Revenue Market Share by Players (2018-2024)
3.2 Global IL-17 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of IL-17 Antibody, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global IL-17 Antibody Market Concentration Ratio
3.4.1 Global IL-17 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IL-17 Antibody Revenue in 2022
3.5 Global Key Players of IL-17 Antibody Head office and Area Served
3.6 Global Key Players of IL-17 Antibody, Product and Application
3.7 Global Key Players of IL-17 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IL-17 Antibody Breakdown Data by Type
4.1 Global IL-17 Antibody Historic Market Size by Type (2018-2024)
4.2 Global IL-17 Antibody Forecasted Market Size by Type (2024-2029)
5 IL-17 Antibody Breakdown Data by Application
5.1 Global IL-17 Antibody Historic Market Size by Application (2018-2024)
5.2 Global IL-17 Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America IL-17 Antibody Market Size (2018-2029)
6.2 North America IL-17 Antibody Market Size by Type
6.2.1 North America IL-17 Antibody Market Size by Type (2018-2024)
6.2.2 North America IL-17 Antibody Market Size by Type (2024-2029)
6.2.3 North America IL-17 Antibody Market Share by Type (2018-2029)
6.3 North America IL-17 Antibody Market Size by Application
6.3.1 North America IL-17 Antibody Market Size by Application (2018-2024)
6.3.2 North America IL-17 Antibody Market Size by Application (2024-2029)
6.3.3 North America IL-17 Antibody Market Share by Application (2018-2029)
6.4 North America IL-17 Antibody Market Size by Country
6.4.1 North America IL-17 Antibody Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America IL-17 Antibody Market Size by Country (2018-2024)
6.4.3 North America IL-17 Antibody Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe IL-17 Antibody Market Size (2018-2029)
7.2 Europe IL-17 Antibody Market Size by Type
7.2.1 Europe IL-17 Antibody Market Size by Type (2018-2024)
7.2.2 Europe IL-17 Antibody Market Size by Type (2024-2029)
7.2.3 Europe IL-17 Antibody Market Share by Type (2018-2029)
7.3 Europe IL-17 Antibody Market Size by Application
7.3.1 Europe IL-17 Antibody Market Size by Application (2018-2024)
7.3.2 Europe IL-17 Antibody Market Size by Application (2024-2029)
7.3.3 Europe IL-17 Antibody Market Share by Application (2018-2029)
7.4 Europe IL-17 Antibody Market Size by Country
7.4.1 Europe IL-17 Antibody Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe IL-17 Antibody Market Size by Country (2018-2024)
7.4.3 Europe IL-17 Antibody Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China IL-17 Antibody Market Size (2018-2029)
8.2 China IL-17 Antibody Market Size by Type
8.2.1 China IL-17 Antibody Market Size by Type (2018-2024)
8.2.2 China IL-17 Antibody Market Size by Type (2024-2029)
8.2.3 China IL-17 Antibody Market Share by Type (2018-2029)
8.3 China IL-17 Antibody Market Size by Application
8.3.1 China IL-17 Antibody Market Size by Application (2018-2024)
8.3.2 China IL-17 Antibody Market Size by Application (2024-2029)
8.3.3 China IL-17 Antibody Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia IL-17 Antibody Market Size (2018-2029)
9.2 Asia IL-17 Antibody Market Size by Type
9.2.1 Asia IL-17 Antibody Market Size by Type (2018-2024)
9.2.2 Asia IL-17 Antibody Market Size by Type (2024-2029)
9.2.3 Asia IL-17 Antibody Market Share by Type (2018-2029)
9.3 Asia IL-17 Antibody Market Size by Application
9.3.1 Asia IL-17 Antibody Market Size by Application (2018-2024)
9.3.2 Asia IL-17 Antibody Market Size by Application (2024-2029)
9.3.3 Asia IL-17 Antibody Market Share by Application (2018-2029)
9.4 Asia IL-17 Antibody Market Size by Region
9.4.1 Asia IL-17 Antibody Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia IL-17 Antibody Market Size by Region (2018-2024)
9.4.3 Asia IL-17 Antibody Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America IL-17 Antibody Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America IL-17 Antibody Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America IL-17 Antibody Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America IL-17 Antibody Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific IL-17 Antibody Introduction
11.1.4 Thermo Fisher Scientific Revenue in IL-17 Antibody Business (2018-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 ProSci
11.2.1 ProSci Company Details
11.2.2 ProSci Business Overview
11.2.3 ProSci IL-17 Antibody Introduction
11.2.4 ProSci Revenue in IL-17 Antibody Business (2018-2024)
11.2.5 ProSci Recent Developments
11.3 FineTest
11.3.1 FineTest Company Details
11.3.2 FineTest Business Overview
11.3.3 FineTest IL-17 Antibody Introduction
11.3.4 FineTest Revenue in IL-17 Antibody Business (2018-2024)
11.3.5 FineTest Recent Developments
11.4 Sino Biological
11.4.1 Sino Biological Company Details
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological IL-17 Antibody Introduction
11.4.4 Sino Biological Revenue in IL-17 Antibody Business (2018-2024)
11.4.5 Sino Biological Recent Developments
11.5 Miltenyi Biotec
11.5.1 Miltenyi Biotec Company Details
11.5.2 Miltenyi Biotec Business Overview
11.5.3 Miltenyi Biotec IL-17 Antibody Introduction
11.5.4 Miltenyi Biotec Revenue in IL-17 Antibody Business (2018-2024)
11.5.5 Miltenyi Biotec Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck IL-17 Antibody Introduction
11.6.4 Merck Revenue in IL-17 Antibody Business (2018-2024)
11.6.5 Merck Recent Developments
11.7 Santa Cruz Biotechnology
11.7.1 Santa Cruz Biotechnology Company Details
11.7.2 Santa Cruz Biotechnology Business Overview
11.7.3 Santa Cruz Biotechnology IL-17 Antibody Introduction
11.7.4 Santa Cruz Biotechnology Revenue in IL-17 Antibody Business (2018-2024)
11.7.5 Santa Cruz Biotechnology Recent Developments
11.8 Proteintech
11.8.1 Proteintech Company Details
11.8.2 Proteintech Business Overview
11.8.3 Proteintech IL-17 Antibody Introduction
11.8.4 Proteintech Revenue in IL-17 Antibody Business (2018-2024)
11.8.5 Proteintech Recent Developments
11.9 United States Biological
11.9.1 United States Biological Company Details
11.9.2 United States Biological Business Overview
11.9.3 United States Biological IL-17 Antibody Introduction
11.9.4 United States Biological Revenue in IL-17 Antibody Business (2018-2024)
11.9.5 United States Biological Recent Developments
11.10 BioLegend
11.10.1 BioLegend Company Details
11.10.2 BioLegend Business Overview
11.10.3 BioLegend IL-17 Antibody Introduction
11.10.4 BioLegend Revenue in IL-17 Antibody Business (2018-2024)
11.10.5 BioLegend Recent Developments
11.11 Bio-Rad
11.11.1 Bio-Rad Company Details
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad IL-17 Antibody Introduction
11.11.4 Bio-Rad Revenue in IL-17 Antibody Business (2018-2024)
11.11.5 Bio-Rad Recent Developments
11.12 Bio X Cell
11.12.1 Bio X Cell Company Details
11.12.2 Bio X Cell Business Overview
11.12.3 Bio X Cell IL-17 Antibody Introduction
11.12.4 Bio X Cell Revenue in IL-17 Antibody Business (2018-2024)
11.12.5 Bio X Cell Recent Developments
11.13 Hytest
11.13.1 Hytest Company Details
11.13.2 Hytest Business Overview
11.13.3 Hytest IL-17 Antibody Introduction
11.13.4 Hytest Revenue in IL-17 Antibody Business (2018-2024)
11.13.5 Hytest Recent Developments
11.14 Everest Biotech
11.14.1 Everest Biotech Company Details
11.14.2 Everest Biotech Business Overview
11.14.3 Everest Biotech IL-17 Antibody Introduction
11.14.4 Everest Biotech Revenue in IL-17 Antibody Business (2018-2024)
11.14.5 Everest Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global IL-17 Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global IL-17 Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global IL-17 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global IL-17 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global IL-17 Antibody Market Share by Region (2018-2024)
Table 8. Global IL-17 Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global IL-17 Antibody Market Share by Region (2024-2029)
Table 10. IL-17 Antibody Market Trends
Table 11. IL-17 Antibody Market Drivers
Table 12. IL-17 Antibody Market Challenges
Table 13. IL-17 Antibody Market Restraints
Table 14. Global IL-17 Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global IL-17 Antibody Revenue Share by Players (2018-2024)
Table 16. Global Top IL-17 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-17 Antibody as of 2022)
Table 17. Global IL-17 Antibody Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by IL-17 Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of IL-17 Antibody, Headquarters and Area Served
Table 20. Global Key Players of IL-17 Antibody, Product and Application
Table 21. Global Key Players of IL-17 Antibody, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IL-17 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global IL-17 Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global IL-17 Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global IL-17 Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global IL-17 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global IL-17 Antibody Revenue Share by Application (2018-2024)
Table 29. Global IL-17 Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global IL-17 Antibody Revenue Share by Application (2024-2029)
Table 31. North America IL-17 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America IL-17 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America IL-17 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America IL-17 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America IL-17 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America IL-17 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America IL-17 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe IL-17 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe IL-17 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe IL-17 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe IL-17 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe IL-17 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe IL-17 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe IL-17 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 45. China IL-17 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 46. China IL-17 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 47. China IL-17 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 48. China IL-17 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia IL-17 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia IL-17 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia IL-17 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia IL-17 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia IL-17 Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia IL-17 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia IL-17 Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America IL-17 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America IL-17 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America IL-17 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America IL-17 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America IL-17 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America IL-17 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America IL-17 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific IL-17 Antibody Product
Table 66. Thermo Fisher Scientific Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Developments
Table 68. ProSci Company Details
Table 69. ProSci Business Overview
Table 70. ProSci IL-17 Antibody Product
Table 71. ProSci Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 72. ProSci Recent Developments
Table 73. FineTest Company Details
Table 74. FineTest Business Overview
Table 75. FineTest IL-17 Antibody Product
Table 76. FineTest Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 77. FineTest Recent Developments
Table 78. Sino Biological Company Details
Table 79. Sino Biological Business Overview
Table 80. Sino Biological IL-17 Antibody Product
Table 81. Sino Biological Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 82. Sino Biological Recent Developments
Table 83. Miltenyi Biotec Company Details
Table 84. Miltenyi Biotec Business Overview
Table 85. Miltenyi Biotec IL-17 Antibody Product
Table 86. Miltenyi Biotec Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 87. Miltenyi Biotec Recent Developments
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck IL-17 Antibody Product
Table 91. Merck Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 92. Merck Recent Developments
Table 93. Santa Cruz Biotechnology Company Details
Table 94. Santa Cruz Biotechnology Business Overview
Table 95. Santa Cruz Biotechnology IL-17 Antibody Product
Table 96. Santa Cruz Biotechnology Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 97. Santa Cruz Biotechnology Recent Developments
Table 98. Proteintech Company Details
Table 99. Proteintech Business Overview
Table 100. Proteintech IL-17 Antibody Product
Table 101. Proteintech Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 102. Proteintech Recent Developments
Table 103. United States Biological Company Details
Table 104. United States Biological Business Overview
Table 105. United States Biological IL-17 Antibody Product
Table 106. United States Biological Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 107. United States Biological Recent Developments
Table 108. BioLegend Company Details
Table 109. BioLegend Business Overview
Table 110. BioLegend IL-17 Antibody Product
Table 111. BioLegend Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 112. BioLegend Recent Developments
Table 113. Bio-Rad Company Details
Table 114. Bio-Rad Business Overview
Table 115. Bio-Rad IL-17 Antibody Product
Table 116. Bio-Rad Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 117. Bio-Rad Recent Developments
Table 118. Bio X Cell Company Details
Table 119. Bio X Cell Business Overview
Table 120. Bio X Cell IL-17 Antibody Product
Table 121. Bio X Cell Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 122. Bio X Cell Recent Developments
Table 123. Hytest Company Details
Table 124. Hytest Business Overview
Table 125. Hytest IL-17 Antibody Product
Table 126. Hytest Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 127. Hytest Recent Developments
Table 128. Everest Biotech Company Details
Table 129. Everest Biotech Business Overview
Table 130. Everest Biotech IL-17 Antibody Product
Table 131. Everest Biotech Revenue in IL-17 Antibody Business (2018-2024) & (US$ Million)
Table 132. Everest Biotech Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IL-17 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global IL-17 Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global IL-17 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global IL-17 Antibody Market Share by Application: 2022 VS 2029
Figure 7. Enzyme Linked Immunosorbent Assay Case Studies
Figure 8. Immunohistochemistry Frozen Case Studies
Figure 9. Immunohistochemistry Paraffin Case Studies
Figure 10. Western Blot Case Studies
Figure 11. Others Case Studies
Figure 12. IL-17 Antibody Report Years Considered
Figure 13. Global IL-17 Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global IL-17 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global IL-17 Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global IL-17 Antibody Market Share by Players in 2022
Figure 17. Global Top IL-17 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-17 Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by IL-17 Antibody Revenue in 2022
Figure 19. North America IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America IL-17 Antibody Market Share by Type (2018-2029)
Figure 21. North America IL-17 Antibody Market Share by Application (2018-2029)
Figure 22. North America IL-17 Antibody Market Share by Country (2018-2029)
Figure 23. United States IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe IL-17 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe IL-17 Antibody Market Share by Type (2018-2029)
Figure 27. Europe IL-17 Antibody Market Share by Application (2018-2029)
Figure 28. Europe IL-17 Antibody Market Share by Country (2018-2029)
Figure 29. Germany IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China IL-17 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China IL-17 Antibody Market Share by Type (2018-2029)
Figure 37. China IL-17 Antibody Market Share by Application (2018-2029)
Figure 38. Asia IL-17 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia IL-17 Antibody Market Share by Type (2018-2029)
Figure 40. Asia IL-17 Antibody Market Share by Application (2018-2029)
Figure 41. Asia IL-17 Antibody Market Share by Region (2018-2029)
Figure 42. Japan IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America IL-17 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America IL-17 Antibody Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America IL-17 Antibody Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America IL-17 Antibody Market Share by Country (2018-2029)
Figure 52. Brazil IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries IL-17 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 59. ProSci Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 60. FineTest Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 61. Sino Biological Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 62. Miltenyi Biotec Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 63. Merck Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 64. Santa Cruz Biotechnology Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 65. Proteintech Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 66. United States Biological Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 67. BioLegend Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 68. Bio-Rad Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 69. Bio X Cell Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 70. Hytest Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 71. Everest Biotech Revenue Growth Rate in IL-17 Antibody Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed